Medical treatment of endometriosis in infertile patients
Medical treatment of endometriosis, including analgesia, estrogen/progestogen, or progestogen therapy, can achieve 60-70% pregnancy success rates in infertile patients with minimal to moderate disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews medical management of endometriosis in infertile patients, describing use of simple analgesia, combined estrogen/progestogen therapy, progestogen therapy alone, and danazol (about 400 mg daily for at least six months). It reports pregnancy success rates around 60–70% overall, dropping to about 35–56% when associated factors such as oligospermia or pelvic inflammatory disease are present, with higher pregnancy rates in moderate than extensive disease. Recurrence after stopping therapy is described as 17% at one year up to 50% after nine years, and drug side effects are noted as dose-related and include androgenic symptoms, pituitary-gonadal inhibition effects, systemic effects, and blood chemistry disorders. This paper is centrally about endometriosis in infertile patients, focusing on the outcomes and adverse effects of hormonal and danazol-based medical treatments.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
3,943 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (21)
- Antigonadotropin (danazol) in the treatment of endometriosis via openalex
- A STUDY OF PLASMA PROGESTERONE, OESTRADIOL‐l7β, PROLACTIN AND LH LEVELS, AND OF THE LUTEAL PHASE APPEARANCE OF THE OVARIES IN PATIENTS WITH ENDOMETRIOSIS AND INFERTILITY via openalex
- Clinical and biochemical experiences with danazol in the treatment of endometriosis in cases with female infertility. via openalex
- Combined laparoscopic surgery and danazol therapy for pelvic endometriosis via openalex
- Danazol—A Steroid with a Unique Combination of Actions via openalex
- Danazol in the Treatment of Endometriosis via openalex
- Danazol in the treatment of endometriosis externa. via openalex
- Danazol May Cause Female Pseudohermaphroditism via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Effect of norethynodrel on endometriosis via openalex
- Endometriosis: Treatment with hormonal pseudopregnancy and/or operation via openalex
- Infertility with Endometriosis via openalex
- Management of pelvic endometriosis with low-dose danazol via openalex
- Management of Pelvic Endometriosis with Low-Dose Danazol via openalex
- Pharmacology and Pharmacokinetics of Danazol via openalex
- Review: The Mechanism of Action of Danazol, a Novel Steroid Derivative via openalex
- TREATMENT OF ENDOMETRIOSIS: A STUDY OF MEDICAL MANAGEMENT via openalex
- W4254982405 via openalex
- W2395322658 via openalex
- W2411454725 via openalex
- W1618997004 via openalex
Source provenance
- europepmc
- last seen: 2026-07-29T06:27:48.050232+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:55.985569+00:00